Arteris, Inc. (NASDAQ:AIP – Get Free Report) was the recipient of a large decrease in short interest in November. As of November 15th, there was short interest totalling 509,900 shares, a decrease of 14.2% from the October 31st total of 594,400 shares. Based on an average daily volume of 106,900 shares, the days-to-cover ratio is currently 4.8 days. Currently, 2.0% of the company’s shares are sold short.
Arteris Price Performance
Shares of NASDAQ AIP opened at $8.61 on Tuesday. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. The firm has a market capitalization of $345.92 million, a PE ratio of -8.97 and a beta of 1.13. Arteris has a 1-year low of $4.83 and a 1-year high of $9.54. The business’s fifty day moving average price is $7.65 and its two-hundred day moving average price is $7.75.
Insider Buying and Selling
In other news, CFO Nicholas B. Hawkins sold 19,299 shares of the company’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $8.14, for a total value of $157,093.86. Following the completion of the sale, the chief financial officer now owns 192,414 shares of the company’s stock, valued at $1,566,249.96. This represents a 9.12 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Paul L. Alpern sold 3,615 shares of the firm’s stock in a transaction dated Friday, October 4th. The shares were sold at an average price of $7.13, for a total value of $25,774.95. Following the sale, the vice president now owns 68,084 shares in the company, valued at approximately $485,438.92. The trade was a 5.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 129,751 shares of company stock valued at $951,813. 33.70% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Arteris
Analyst Ratings Changes
Separately, Rosenblatt Securities reiterated a “buy” rating and set a $15.00 target price on shares of Arteris in a research note on Wednesday, November 6th.
View Our Latest Analysis on Arteris
Arteris Company Profile
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Further Reading
- Five stocks we like better than Arteris
- The 3 Best Blue-Chip Stocks to Buy Now
- How to Master Trading Discipline: Overcome Emotional Challenges
- What is Put Option Volume?
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- Retail Stocks Investing, Explained
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.